Arthur Altschul - General American Insider

XGAMX -- USA Fund  

USD 44.16  0.02  0.0453%

  Director
Mr. Arthur G. Altschul, Jr. is Independent Director of General American Investors Company, Inc. In addition to his tenure since 1995 as a Director of the Company, Mr. Altschul is CoFounder and Chairman of Kolltan Pharmaceuticals, Inc. a founder and Managing Member of Diaz Altschul Capital Management, LLC and Chairman of Overbrook Management Corporationrationration . Mr. Altschul served as a Director from 1992 to December 2012 and was a member of the Audit Committee of Medicis Pharmaceutical Corporationrationration until it was acquired by and merged into Valeant Pharmaceuticals International in December 2012. From 1992 to 1996, Mr. Altschul worked at SUGEN, Inc. a biopharmaceutical firm. Prior to 1992, Mr. Altschul worked in the Equity and Fixed Income Trading departments at Goldman, Sachs Co. was a founding limited partner of The Maximus Fund, LP, and worked in the Equity Research department at Morgan Stanley Company. Mr. Altschul is a Director of Delta Opportunity Fund, Ltd., an investment fund which invests primarily in the health care industry. Mr. Altschul serves on the Board of Directors of Child Mind Institute and is a Trustee of the Neurosciences Research Foundation
Age: 51  Director Since 1995      
Altschul holds a B.S. from Columbia University in Computer Science.

Arthur Altschul Latest Insider Activity

Management Performance (%)

Fund Summary

The fund is listed under null category and is part of null family.

General American Inv Leadership Team

Diane Radosti, Principal Accounting Officer, Treasurer
Henry Schirmer, Director
Rose Lynch, Director
Andrew Vindigni, Senior Vice President
Clara Villar, Director
Linda Genid, Assistant Corporate Secretary
Arthur Altschul, Independent Director
Lewis Cullman, Independent Director
Jeffrey Priest, President
Spencer Davidson, Chairman of the Board, CEO
Anang Majmudar, Vice President
Eugene Stark, Principal Financial Officer, Vice President - Administration, Chief Compliance Officer
Sidney Knafel, Lead Independent Director
Betsy Gotbaum, Independent Director
Maureen LoBello, Assistant Secretary
Craig Grassi, Assistant Vice-President
Sally Lynch, Vice President
Michael Robinson, Vice President
Raymond Troubh, Independent Director
Rodney Berens, Independent Director
Daniel Neidich, Independent Director
John Gordan, Independent Director

Fund Performance Indicators

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Price Transformation

Also Currentnly Active

Purchased a lot of shares of
a day ago
Traded for 156.0
Purchased a lot of shares of
a day ago
Traded for 156.0
Purchased over 300 shares of
a day ago
Traded for 9.81
See also Your Current Watchlist. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com